1.33
price down icon5.00%   -0.07
pre-market  Vorhandelsmarkt:  1.34   0.01   +0.75%
loading

Finanzdaten der Citius Pharmaceuticals Inc-Aktie (CTXR)

Gewinn- und Verlustrechnung
Vierteljährlich
*Alle Zahlen in Millionen
Enddatum des Zeitraums 2025-06-30 2025-03-31 2024-12-30 2024-09-30 2024-06-30
Periodenlänge 3 Monate 3 Monate 3 Monate 3 Monate 3 Monate
Revenues
-
- - - -
Operating Expenses
21.96%
8.788
11.26 10.04 11.05 10.63
Operating Income/Loss
21.96%
-8.788
-11.26 -10.04 -11.05 -10.63
Nonoperating Income/Loss
1,230%
-0.1516
0.0134 0.0226 0.1173 0.2048
Income/Loss From Continuing Operations Before Tax
20.52%
-8.9396
-11.25 -10.28 -10.93 -10.43
Income Tax Expense/Benefit, Deferred
0.2642
- - 0.144 0.144
Income Tax Expense/Benefit
0.00%
0.2642
0.2642 0.2642 0.144 0.144
Income/Loss From Continuing Operations After Tax
20.05%
-9.2039
-11.51 -10.28 -11.08 -10.57
Net Income/Loss
20.05%
-9.2039
-11.51 -10.28 -11.08 -10.57
Preferred Stock Dividends And Other Adjustments
-
- - -0.3216 0.3216
Attributable To Noncontrolling Interest
30.42%
-0.414
-0.595 - -0.287 -
Basic Average Shares
28.27%
11.01
8.5812 -0.5514 -157.22 173.86
Diluted Average Shares
28.27%
11.01
8.5812 -0.5514 -157.22 173.86
Basic Earnings Per Share
37.01%
-0.80
-1.27 -1.31 - -
Diluted Earnings Per Share
37.01%
-0.80
-1.27 -1.31 - -
Participating Securities, Distributed And Undistributed Earnings/Loss, Basic
-
- - -0.3216 0.3216
$24.87
price down icon 0.96%
$84.61
price up icon 1.09%
$23.70
price down icon 2.95%
$100.00
price down icon 1.89%
$136.10
price up icon 0.84%
biotechnology ONC
$306.05
price up icon 2.72%
Kapitalisierung:     |  Volumen (24h):